Crystalloid Administration Is Associated with the Recovery of Pediatric Elective Roux-en-Y Hepaticojejunostomy

Xingqin Tan1,2, Jianxia Liu1,2, Chunbao Guo2,3

  • 1Department of Anesthesiology, Children's Hospital, Chongqing Medical University, Chongqing, China.

Insights

Low intraoperative crystalloid fluid administration in Roux-en-Y hepaticojejunostomy patients was linked to better gastrointestinal recovery and fewer complications. This finding suggests optimizing fluid management can improve patient outcomes.

Area of Science:

  • Surgery
  • Anesthesiology
  • Gastroenterology

Background:

  • Intraoperative fluid administration is crucial for patient recovery after surgery.
  • Fluid management strategies may influence postoperative complications.

Purpose of the Study:

  • To investigate the association between intraoperative crystalloid fluid volumes and postoperative outcomes in patients undergoing Roux-en-Y hepaticojejunostomy.
  • To compare clinical outcomes between patients receiving low versus high fluid volumes.

Main Methods:

  • Retrospective review of 471 patients who underwent Roux-en-Y hepaticojejunostomy.
  • Patients were categorized into low (<15.27 mL/kg/h) and high (>15.27 mL/kg/h) crystalloid fluid groups.
  • Propensity score matching was used to compare outcomes in 192 matched patients.

Main Results:

  • Low crystalloid fluid administration was associated with earlier first defecation and bowel movement.
  • Patients receiving low fluid volumes had a lower overall postoperative complication rate.
  • The high fluid group experienced a longer hospital stay (9.21 days) compared to the low fluid group (7.83 days).
  • No significant difference in renal complications was observed between groups.

Conclusions:

  • Lower intraoperative crystalloid fluid administration is associated with favorable postoperative outcomes.
  • Optimizing fluid management may enhance gastrointestinal recovery and reduce complications after Roux-en-Y hepaticojejunostomy.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
4.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
292
Additional Routes of Drug Administration01:18

Additional Routes of Drug Administration

Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
4.9K